
- BioPharm International-01-01-2002
- Volume 15
- Issue 1
Considerations During Development of a Protein A-Based Antibody Purification Process
by Harish Iyer, Felicia Henderson, Eric Cunningham, James Welbb, John Hanson, Christopher Bork, and Lynn Conley, IDEC Pharmaceuticals Corporation Scale-up changes in an antibody purification process can increase final product purity, make the process more robust, and reduce processing time. This case study focuses on the initial purification step -- protein A chromatography -- and offers data collected from several years of process development work on many different antibodies.
Articles in this issue
almost 24 years ago
Outsourcing Outlook: E-Sourcing, Internet Facilitates Flexible Collaborationalmost 24 years ago
Inside Washington: Biotechnology in the Limelight, the Year Aheadalmost 24 years ago
Your Vested Interests: The War of the Westalmost 24 years ago
Statistics for Laboratory Method Comparison Studiesalmost 24 years ago
From the Editor: Farewell to 2001 . . . Our Biotech Odyssey Continuesalmost 24 years ago
Liposomes (a Review): Part Two, Drug Delivery Systemsalmost 24 years ago
Information Age AuditsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.





